Voz media US Voz.us
Apple store Voz-media Play store Voz Media

FDA approves over-the-counter birth control pill

Opill, a hormonal contraceptive pill, can cause side effects such as irregular bleeding, headaches, dizziness, nausea, and abdominal pain.

Píldora anticonceptiva. Imagen de archivo.

(Pxfuel)

Published by
Alejandro Baños

The Food and Drug Administration (FDA) authorized the sale of the first over-the-counter hormonal birth control pill, Opill, although it has not been confirmed when it will be available to the public. This is progressives' newest way of imposing their agenda on women's reproductive and sexual rights without considering other opinions.

In a statement, the director of the FDA's Center for Drug Evaluation and Research, Patrizia Cavazzoni, confirmed the news and assured that it will provide greater efficacy than other contraceptive methods:

Today's approval marks the first time a daily over-the-counter oral contraceptive will be an option available to millions of people in the United States. When used as directed, daily oral contraceptives such as Opill are safe and are expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancies.

The Department of Health and Human Services (HHS) confirmed that Opill will be available in pharmacies, convenience stores, supermarkets and online. A prescription will still be required to purchase any other contraceptive medications.

The price of the non-prescription contraceptive pill will be set by the manufacturer. According to the FDA, there are around three million unintended pregnancies every year.

Possible side effects

The FDA warns that the nonprescription contraceptive pill must be taken at the same time every day. The federal agency explained that if women do not follow these instructions, they could experience side effects such as "irregular bleeding, headaches, dizziness, nausea, increased appetite, abdominal pain, cramps or bloating."

In addition, taking other medicine with Opill could reduce the effectiveness of both drugs.

tracking